We respect your privacy. Please consent to all cookies when you visit our website. Refer to our "Privacy Policy" for more information on how we handle personal data.

EN
  • 20.png
CE|ANVISA|NMPA Registration No. 20203400065

2019-nCoV Nucleic Acid Detection Kit (Fluorescent PCR Method)

  • Accelerated & Rapid

    Preferred brand recommended by 5,000 medical institutions, completing amplification in just 35–75 min

  • Dual-Target

    ORF1ab and N Gene Detection

  • Endogenous Internal Control (RNP)

    Includes an internal control to monitor sampling, extraction and detection processes, ensuring reliable results.

  • Higher Sensitivity

    Limit of detection (LoD) is 150 copies/mL, perfectly suited for 10-in-1 and 20-in-1 pooled testing to efficiently handle large-scale screening

image.png